Every Form 4 that USBC, Inc. (USBC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow USBC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full USBC filings page.
USBC, Inc. director William Arthur Owens received a grant of options to purchase 120,000 shares of common stock on August 12, 2026 at an exercise price of $0.36 per share, expiring August 12, 2036. The options vest as to 10,000 shares on September 30, 2026 and in eleven additional quarterly installments of 10,000 shares through June 30, 2029. Following this grant, he holds options on 120,000 shares, a warrant covering 500 shares at $68.00 per share (reflecting a prior 1-for-40 reverse stock split), and 48,692 shares of common stock directly.
USBC, Inc. director Takesako Ichiro received a compensatory grant of options on 120,000 shares of common stock on August 12, 2026 under the Amended and Restated 2021 Equity Incentive Plan. The options have a $0.36 exercise price, vest as to 10,000 shares on September 30, 2026 and in eleven quarterly installments of 10,000 shares through June 30, 2029, and expire on August 12, 2036. Following this grant, he directly holds options on 120,000 shares, a warrant covering 500 shares at $68.00 per share, and 28,875 shares of common stock, all figures reflecting a 1-for-40 reverse stock split effective February 19, 2025.
USBC, Inc. reported that director Jon Pepper received a grant of stock options for 120,000 shares of common stock at an exercise price of $0.36 per share, expiring on August 12, 2036. The options vest as to 10,000 shares on September 30, 2026 and in eleven quarterly installments of 10,000 shares through June 30, 2029. Following this award, Pepper holds 37,850 shares of common stock directly and a warrant covering 500 shares at an exercise price of $68.00, which reflects a 1-for-40 reverse stock split effective February 19, 2025.
USBC, Inc. reported that director Larry K. Ellingson received a compensatory grant of an option to purchase 120,000 shares of common stock at an exercise price of $0.36 per share. The option expires on August 12, 2036 and vests 10,000 shares on September 30, 2026 and in eleven quarterly installments of 10,000 shares through June 30, 2029. Following this grant, Ellingson directly holds 25,404 shares of USBC common stock.
USBC, Inc. director Linda Jenkinson repriced 10,000,000 stock options on common shares. An existing option covering 10,000,000 shares with a $1.10 exercise price was returned to the company, and a new option for 10,000,000 shares was granted at a $0.37 exercise price.
According to the company’s Amended and Restated 2021 Equity Incentive Plan, the repriced option vests as to 25% of the covered shares on the one-year anniversary of the applicable grant date and then in quarterly installments over the following three years, aligning compensation with long-term service.
USBC, Inc. reported that CFO, Treasurer and Secretary Kitty B. Payne had 3,750,000 stock options repriced. Existing options with a $1.10 per-share exercise price were returned to the company and replaced with options at a reduced $0.37 per-share exercise price.
The repriced options cover 3,750,000 shares of common stock and were granted under the Amended and Restated 2021 Equity Incentive Plan. They vest 25% on the one-year anniversary of the original grant dates and then in quarterly installments over the following three years.
USBC, Inc. reporting person Kitty B. Payne, who serves as CFO/Treasurer/Secretary and a director, disclosed option activity on 10/07/2025. The Board approved a repricing that reduced the exercise price on 1,790,000 outstanding options from $2.45 to $1.10. The reporting person also received a new grant of 1,960,000 options exercisable at $1.10. After these transactions the reporting person beneficially owns 3,750,000 underlying shares via options, all exercisable through 2035 with standard vesting of 25% after one year and quarterly installments over three years thereafter.
The repricing and new grant increase the reporting persons option exposure and lower near-term strike prices, which may affect dilution and align executive incentives with current share value. All terms disclosed are pursuant to the Amended and Restated 2021 Equity Incentive Plan.
Insider option activity: A director, Linda Jenkinson, reported option repricings and new grants on 10/07/2025 for USBC, Inc. The Board approved lowering the exercise price of previously granted options from $2.45 to $1.10 for 4,760,000 shares. The reporting person also received two option grants: one repriced option covering 4,760,000 shares and a new option for 5,240,000 shares, creating total option exposure to 10,000,000 underlying shares exercisable through 2035. Each option vests 25% after one year then quarterly over three years.
USBC insider option activity: The company's Chief Operating Officer participated in targeted option adjustments and a new grant. Outstanding options covering 7,140,000 shares were repriced from $2.45 to $1.10 and remain subject to the original vesting schedule that vests 25% after one year with quarterly vesting thereafter. In addition, a new option for 7,860,000 shares was granted at an exercise price of $1.10 with the same vesting pattern, producing a total of 15,000,000 underlying shares held after the transactions. The repriced and newly granted options have exercise windows stretching to 2035 and carry standard multi-year vesting to align with future service.